FDA Bulk Compounding Substance Review: Task For Advisory Committee – Or Sisyphus?
This article was originally published in The Pink Sheet Daily
Executive Summary
Six nominees for the compounding bulk drug substances list will be discussed during the first Pharmacy Compounding Advisory Committee Meeting since its restart, but trade group proposed more than 1,500 for review.